FibroBiologics, Inc. Common Stock
FBLG
$0.99+7.61%
At close · Nov 3, 2026
Mkt cap
$24.02M
EV/Sales
—
P/E ratio
—
Revenue (FY2025)
—
EPS (H1 2026)
−$1.81
Gross Margin (FY2025)
—
Profit Margin (FY2025)
—
Beta
—
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
FBLG earnings
Analysts
RatingsSector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Oct 8, 2026
Latest stored headlines
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Use this FBLG research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FBLG income, balance, and cash tables.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company in the Healthcare sector.
Latest cached FibroBiologics, Inc. Common Stock (FBLG) net income for FY2025 was -$18.6M. Statements: https://lician.com/financials/fblg
FibroBiologics, Inc. Common Stock (FBLG) market capitalization is $24.0M on the latest cached snapshot.
FibroBiologics, Inc. Common Stock (FBLG) cached previous close $0.92; day range $0.90 – $0.99; volume 41,764. Session quote: https://lician.com/quote/fblg
FibroBiologics, Inc. Common Stock (FBLG) latest cached earnings event is "FBLG earnings" on Jul 31, 2026. Earnings calendar: https://lician.com/earnings
The latest cached FBLG filing is 8-K · Oct 8, 2026. Filings: https://lician.com/sec/fblg
SEC filings · latest fiscal year FY2025
Free shows the newest 2 years. FY2022–FY2023 on Pro
—
Revenue growth year over year
10-Q results and the earnings calendar
Revenue and EPS are GAAP diluted from the 10-Q. Beat or miss compares the calendar's actual with its estimate on the same basis (adj.), or revenue with the revenue estimate.
Institutional holders from SEC 13F filings
Quant rating
MetricsHow it works—Not rated: market cap below $100M. Factor grades are still shown.
Lician Quant Grades · vs 548 Healthcare stocks · Nov 4, 2026
Next earnings
Tue, Feb 23Lician estimate
Time not announced · in 111 days
EPS est. —
Lician projectionEarnings
Short interest
1.15%of float
2.4 days to cover
−36.7% vs prior report
FINRA · settled Oct 15Short data
52-week range
$0.63$8.70
Price $0.99 · 88.6% below high
Low $0.63, high $8.70, last $0.99.Daily closesChart
Get alerted when FBLG confirms or moves its Feb 23 report
Free account, no card. Earnings date alerts are free for every stock on your watchlist; beat/miss results come with Pro.